Company · MYGN (NASDAQ - All Markets)
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances
Key figures
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Institutional holders
- 197 at 30 Jun 2026 (203 the quarter before)
- SEC number
- 899923
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 1 Oct 2026
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.